Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Luca, M.
Right arrow Articles by Berndt, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Luca, M.
Right arrow Articles by Berndt, M. C.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 1 (January 1), 2000: pp. 164-172

Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation

Mariagrazia De Luca, David A. Facey, Emmanuel J. Favaloro, Mark S. Hertzberg, James C. Whisstock, Tracy McNally, Robert K. Andrews, and Michael C. Berndt

From the Hazel and Pip Appel Vascular Biology Laboratory, Baker Medical Research Institute, Melbourne; the Department of Hematology, Westmead Hospital, Westmead, New South Wales; and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.

Binding of the adhesive glycoprotein, von Willebrand factor (vWf), to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates platelet adhesion and aggregation at high shear stress in hemostasis and thrombosis. In this study, the GP Ib-IX-V binding site within the vWf A1 domain was analyzed using a panel of murine monoclonal antibodies raised against a 39/34-kd vWf fragment (Leu-480/Val-481-Gly-718) encompassing the A1 domain. One antibody, 6G1, strongly inhibited ristocetin-dependent vWf binding to platelets, but had no effect on botrocetin- or jaracetin-dependent binding, or asialo-vWf-dependent platelet aggregation. The 6G1 epitope was mapped to Glu-700-Asp-709, confirming the importance of this region for modulation of vWf by ristocetin. Like ristocetin, 6G1 activated the vWf A1 domain, because it enhanced binding of the 39/34-kd fragment to platelets. In contrast, 5D2 and CR1 completely inhibited asialo-vWf-induced platelet aggregation and ristocetin-induced vWf binding to GP Ib-IX-V. However, only 5D2 blocked botrocetin- and jaracetin-induced vWf binding to platelets and binding of vWf to botrocetin- and jaracetin-coated beads. Epitopes for 5D2 and CR1 were conformationally dependent, but not congruent. Other antibodies mapped to epitopes within the A1 domain (CR2 and CR15, Leu-494-Leu-512; CR2, Phe-536-Ala-554; CR3, Arg-578-Glu-596; CR11 and CR15, Ala-564-Ser-582) were not functional, identifying regions of the vWf A1 domain not directly involved in vWf-GP Ib-IX-V interaction. The combined results provide evidence that the proline-rich sequence Glu-700-Asp-709 constitutes a regulatory site for ristocetin, and that ristocetin and botrocetin induce, at least in part, separate receptor-recognition sites on vWf. (Blood. 2000;95:164-172)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. S. Buzza, J. M. Dyson, H. Choi, E. E. Gardiner, R. K. Andrews, D. Kaiserman, C. A. Mitchell, M. C. Berndt, J.-F. Dong, and P. I. Bird
Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor
J. Biol. Chem., August 15, 2008; 283(33): 22498 - 22504.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shen, S. L. Cranmer, A. Aprico, J. C. Whisstock, S. P. Jackson, M. C. Berndt, and R. K. Andrews
Leucine-rich Repeats 2-4 (Leu60-Glu128) of Platelet Glycoprotein Ib{alpha} Regulate Shear-dependent Cell Adhesion to von Willebrand Factor
J. Biol. Chem., September 8, 2006; 281(36): 26419 - 26423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nakayama, T. Matsushita, Z. Dong, J. E. Sadler, S. Jorieux, C. Mazurier, D. Meyer, T. Kojima, and H. Saito
Identification of the Regulatory Elements of the Human von Willebrand Factor for Binding to Platelet GPIb. IMPORTANCE OF STRUCTURAL INTEGRITY OF THE REGIONS FLANKED BY THE CYS1272-CYS1458 DISULFIDE BOND
J. Biol. Chem., June 7, 2002; 277(24): 22063 - 22072.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Ni, V. Ramakrishnan, Z. M. Ruggeri, J. M. Papalia, D. R. Phillips, and D. D. Wagner
Increased thrombogenesis and embolus formation in mice lacking glycoprotein V
Blood, July 15, 2001; 98(2): 368 - 373.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-F. Dong, M. C. Berndt, A. Schade, L. V. McIntire, R. K. Andrews, and J. A. Lopez
Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions
Blood, January 1, 2001; 97(1): 162 - 168.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020